Immunity to pathogens critically requires pattern-recognition receptors (PRRs) to trigger intracellular signaling cascades that initiate and direct innate and adaptive immune responses. For fungal infections, these responses are primarily mediated by members of the C-type lectin receptor family. In this Review, we highlight recent advances in the understanding of the roles and mechanisms of these multifunctional receptors, explore how these PRRs orchestrate antifungal immunity and briefly discuss progress in the use of these receptors as targets for antifungal and other vaccines.
Fungi are ubiquitous; we inhale several hundreds of Aspergillus sp. spores each day, most of us are colonized with Candida sp. and other fungal species, and in our lifetimes we will be exposed to hundreds of potentially infective fungal species 1 . With the prevalence of these microorganisms and relatively low incidence of pathogenicity, it is easy to overlook their threat to public health. In reality, however, fungi are robust pathogens that, when given the opportunity to cause infection, particularly in immunocompromised individuals, establish lifelong or life-threatening diseases for which current diagnostic techniques and treatment options are unacceptably limited 1 . Dermatological infections of the skin, nails and mucosa occur in an estimated 25% of the worldwide population, and although the incidence of invasive fungal infections is considerably lower, such infections are of greater concern because of the resulting extremely high mortality rate 1 . Cryptococcal meningitis, disseminated candidiasis and invasive pulmonary aspergillosis, for example, can result in 30-80% mortality during treatment and are 100% fatal if not diagnosed correctly 1 . It is worrying that recent decades have seen drastic increases in the incidence of invasive fungal infection, which is due primarily to modern medical practices, such as immunosuppressive therapy, and the HIV and AIDS pandemic.
The ability of healthy individuals to cope with the continual exposure to fungal pathogens indicates that our immune system has effective mechanisms for preventing infections with these organisms. Although our understanding of these mechanisms has lagged behind that of other pathogens, substantial progress has been made over the last few years, and it is hoped that we will ultimately be able to use our growing knowledge to develop novel immunotherapeutic approaches for the treatment of these devastating diseases. One fundamental insight has been the realization that C-type lectin receptors (CLRs) have central roles in immunity to fungal pathogens. In this Review, we highlight the importance of CLRs in antifungal immunity and explore the roles and mechanisms used by these receptors to induce and modulate innate and adaptive responses. We will also describe how these receptors can collaborate with other PRRs and discuss strategies used to target these receptors for driving tailored immune responses for vaccines.
The key role of CLRs
To date, four families of PRRs have been shown to recognize pathogens and to be capable of inducing cellular responses: the Toll-like receptor (TLR), Nod-like receptor (NLR), RIG-I-like receptor (RLR) and CLR families. The RLRs and NLRs are not thought to contribute directly to fungal recognition, although certain NLRs can be activated by fungi through unknown mechanisms, as discussed below. The TLRs are the best-characterized family of PRRs with regard to other types of pathogens, and they also have been implicated in fungal recognition. Mice lacking MyD88, a central signaling adaptor used by many TLRs (but also IL-1R) are susceptible to infections with several fungal species, including Candida albicans, Paracoccidioides brasiliensis, Aspergillus fumigatus and Cryptococcus neoformans. Furthermore, several TLRs have been implicated in fungal recognition, including TLR1, TLR2, TLR4, TLR6, TLR7 and TLR9 (refs. 2,3) . However, there is contradictory evidence surrounding the individual role of these PRRs, particularly in mouse models, which may be due to variable recognition of different isolates of the same fungal pathogen, as shown for C. albicans 4 . Polymorphisms in TLRs have also been linked to human susceptibility in the context of immunosuppression 5 , but immunocompetent individuals who lack MyD88 and other critical downstream signaling components do not exhibit a predisposition to fungal diseases 6 . Nevertheless, there is emerging evidence that the interaction of TLRs with other PRRs is an integral component of antifungal immunity (discussed below).
In contrast to TLRs, CLRs and their signaling pathways are essential for antifungal immunity. CLRs are part of a heterogeneous superfamily of soluble and transmembrane proteins defined by a characteristic C-type lectin domain 7 , and they bind to most, if not all, fungal species that cause disease in humans. These receptors recognize the major carbohydrate structures that are found in fungal cell walls, including 8 1 8 VOLUME 13 NUMBER 9 SEPTEMBER 2012 nature immunology r e v i e w β-glucan and mannan 8 (Fig. 1) . Notably, no PRR has yet been identified that recognizes chitin, another major component of the cell wall that has demonstrable immunomodulatory activities 9 .
Of particular interest are several CLRs that can induce intracellular signaling upon fungal recognition, including Dectin-1, Dectin-2, mannose receptor, C-type lectin receptor DC-SIGN and Mincle 10 . Whereas Dectin-1 recognizes β-glucan, the other receptors bind various, largely undefined, mannose-based structures found in the mannan layer of the fungal cell wall (Fig. 1) . The responses mediated by these receptors include fungal binding and phagocytosis, induction of antifungal effector mechanisms and the production of various soluble mediators, including cytokines, chemokines and inflammatory lipids 2 . Notably, these receptors also direct and modulate the development of adaptive immunity, particularly responses of T H 1 and T H 17 subsets of helper T cells [11] [12] [13] [14] [15] [16] [17] (discussed below).
Dectin-1, Dectin-2 and Mincle use the signal transduction kinase Syk, which activates MAP kinase, the transcription factor NFAT and, through the PKCδ-CARD9-Bcl-10-MALT1 axis, the transcription factor NF-κB 11, [18] [19] [20] [21] (Fig. 2) . Dectin-1 signals directly via Syk, whereas Dectin-2 and Mincle couple to Syk via the Fc receptor common γ-chain [22] [23] [24] . Both Dectin-1 and DC-SIGN can activate Raf-1 kinase to modulate NF-κB activity, although the proximal mechanisms involved are unclear 12, 13 . Dectin-1 signaling is only activated after Dectin-1 molecules cluster into a 'phagocytic synapse' , from which the regulatory tyrosine phosphatases CD45 and CD148 are excluded 25 . The signal transduction pathway used by the mannose receptor is as-yet undefined. In mouse models, genetic deletion of these CLRs (including Dectin-1, Dectin-2, Mincle and mannose receptor) and their downstream signaling components (including PKCδ or CARD9) results in defective immunity to several fungal pathogens 14, 15, 18, 20, [26] [27] [28] [29] . In humans, polymorphisms in the gene encoding Dectin-1 and mutations in CARD9 have been identified that result in susceptibility to fungal infections, especially mucocutaneous candidiasis 30, 31 . Notably, the phenotype in individuals with mutations in CARD9 was more severe than in those with polymorphisms in the gene encoding Dectin- 1 (refs. 30,31) , indicative of an involvement of other PRRs.
Individual CLRs can recognize many fungal pathogens, and there is clear overlap in the substrate specificities of some of these receptors. Yet there is still some specificity in recognition by these receptors in part owing to the fact that different fungal species expose different carbohydrate structures or because of different morphological forms of the same organism. For example, Dectin-1 can only recognize the yeast form of Candida because exposed β-glucans become masked by mannan upon formation of hyphae 32 . Another example is the mannose receptor, which has been implicated in the recognition of most fungi in vitro, yet in mice this receptor appears only to be required for protective immunity to infections with C. neoformans 29, 33 . Furthermore, and similar to the case with TLRs, CLR recognition can depend on the fungal strain, such as the case with Dectin-1 (ref. 10) and Dectin-2 (ref. 34) , which has implications for our understanding of human susceptibility to these infections.
CLR-dependent control of antifungal immune responses
Phagocytic cells, particularly macrophages and neutrophils, are essential elements of protective antifungal immunity, and loss of these cells or defects in their antimicrobial effector mechanisms results in susceptibility to fungal infection 2 . CLRs mediate many of these effector functions and promote inflammatory responses, which are critically required for controlling fungal infections 10 . Dectin-1, for example, induces the respiratory burst and the production of inflammatory mediators, including eicosanoids, tumor necrosis factor (TNF), interleukins IL-1β, IL-6 and IL-23, and chemokines CCL2, CXCL1 and CCL3 (refs. 10,35,36) . In mouse models of infection with C. albicans and A. fumigatus, loss of Dectin-1 resulted in the animals' failure to mount protective inflammatory responses (defective neutrophil and Figure 1 Structure of the fungal cell wall. Electron micrograph of the fungal cell wall (C. albicans), with carbohydrate-rich layers of the fungal cell wall highlighted: mannan (mannosylated proteins), β-glucan and chitin. Although it provides a rigid framework, which gives these pathogens their shape and protection from the environment, the cell wall is a dynamic structure that changes considerably, particularly during the morphological transitions that many fungi can undergo (yeast to hyphae, for example). Furthermore, some of the internal components, such β-glucans, can be exposed on the fungal surface in specific areas, such as the bud scar in C. albicans 32 . The composition of the cell wall also varies between different fungal species. Several CLRs have been identified that recognize these cell-wall structures, including transmembrane and soluble CLRs. The latter group, consisting of surfactant protein (SP)-A, SP-D and mannose-binding lectin (MBP), opsonise fungi and facilitate their recognition (discussed elsewhere 38 ). The micrograph was provided by J. Ene and N. Gow. r e v i e w monocyte recruitment, defective production of cytokines such as IL-6, G-CSF and others) and a failure to control fungal growth 26, 37 .
All of the signaling CLRs that recognize fungi (Dectin-1, Dectin-2, mannose receptor, DC-SIGN and Mincle) can induce or modulate T H 1 and T H 17 responses 38 , the latter of which is now considered to be a hallmark of antifungal adaptive immunity 39 (Fig. 3) . Although T H 1 responses are essential for the control of systemic fungal infections, in part through the activation of phagocytes by IFN-γ, T H 17 responses appear to be primarily required for protection at the mucosa 40, 41 . Indeed, various defects in T H 17 immunity, including mutations in the transcription factors STAT1 and STAT3, IL-17 and IL17RA have been linked to susceptibility to mucocutaneous infections in man, especially chronic mucocutaneous candidiasis [42] [43] [44] [45] [46] . Other diseases characterized by susceptibility to chronic mucocutaneous candidiasis, such as autoimmune polyendocrine syndrome 1, are also associated with alterations in T H 17 immunity 47, 48 . How T H 17 responses drive protection at the mucosa is unclear, but they are thought to involve IL-17-mediated neutrophil recruitment and IL-22-mediated induction of antimicrobial peptide production by epithelial cells 41 . T H 17 responses may also be involved in controlling systemic infections with some fungi, such as Candida sp. 14 , although there is evidence to suggest that these responses may contribute to pathology and susceptibility to fungal infection in certain settings 49 .
CLRs and their signaling pathways have essential but varied roles in the development of these antifungal immune responses. Notably, CARD9 deficiency renders both mice and humans susceptible to infection with Candida and results in ablated T H 17 and altered T H 1 responses 11, 31 . Reduced T H 17 responses also correlated with susceptibility to mucocutaneous infections in Dectin-1-deficient humans 30 . In mice, deficiency of Dectin-1 or Dectin-2 results in susceptibility to infection with Candida, but only loss of Dectin-2 results in significant alterations in T H 17 responses 14, 15 . Loss of both Dectin-1 and Dectin-2, however, also led to profound reductions in T H 1 responses, demonstrating the importance of receptor cooperation 15 . Notably, Dectin-2 can induce T H 2 immunity in response to house-dust mite allergens 50 , but whether this receptor, or other CLRs, can induce this type of response to fungi needs to be ascertained, as T H 2 immunity is generally considered to contribute to fungal susceptibility 40 .
There have also been important insights into the mechanisms that are used by CLRs to drive adaptive immunity. Stimulation of Dectin-1, for example, induces dendritic cell (DC) maturation and the expression of polarizing cytokines, such as IL-1β, IL-6 and IL-23, which favor T H 17 differentiation 11 . Furthermore, DCs stimulated by Dectin-1 converted a subset of T reg cells into IL-17 producers 51 , and Dectin-1 (along with TLR2) amplified mannose receptor-induced T H 17 responses 17 . The activation of the NF-κB subunit c-Rel by Malt1 (which forms a complex with CARD9 and Bcl-10, discussed above) induces the production of IL-1β and IL-23, and this is essential for T H 17 differentiation mediated by Dectin-1 and Dectin-2 (ref. 34) . In fact, Dectin-2 appears to selectively activate c-Rel 34 , whereas Dectin-1 also activates other NF-κB subunits, including the noncanonical RelB, promoting both T H 1 and T H 17 responses in vitro 12, 34 . However, during pulmonary infection with Aspergillus fumigatus, Dectin-1 actively suppresses IL-12 and IFN-γ production, favoring T H 17 differentiation 52 .
CLRs can also influence the function of γδ and invariant natural killer T (iNKT) cells (Fig. 3) . γδ T cells are potent innate sources of IL-17 and produce this cytokine in response to IL-23 and IL-1β without TCR triggering 53 . This IL-17 is produced in large amounts and before the development of adaptive T H 17 responses 53 . CCR6 + γδ T cells express TLR1, TLR2 and Dectin-1, and triggering of these receptors directly induced IL-17 production in these cells-a response that could be amplified by IL-23 (ref. 54). C. albicans hyphae, but not yeast, can recruit and stimulate γδ T cells in vivo 54 . iNKT cells, in contrast, do not respond directly to fungi, although they are required for the control of fungal pathogens in vivo 55, 56 . IL-12 production by DCs after stimulation of Dectin-1 or TLRs enabled CD1d-restricted self-reactive iNKT cells to produce IFN-γ 56 . Although Dectin-1 normally suppresses IL-12 production by DCs, as discussed above, co-culture of DCs with iNKT cells potently restored production of this cytokine 56 . Such iNKT responses could be initiated by several fungal species, including A. fumigatus, C. albicans, Histoplasma caspulatum and Alternaria alternata 56 . Thus, the CLR-mediated responses of γδ and iNKT cells may represent key early steps in the development of protective antifungal immune responses.
CLR and TLR collaboration
The recognition of intact pathogens involves multiple PRRs, and we are just starting to understand the 'crosstalk' that can occur between these receptors 57 . As we have seen, fungi are recognized by several CLRs and TLRs, all of which are required for optimal antifungal responses 58 , and there are now several examples where direct interactions between these receptor families have been demonstrated to occur. Indeed, collaborative responses induced by Dectin-1 and TLR-2 were one of the first such interactions described 59, 60 . Dectin-1 can collaborate with multiple MyD88-coupled TLRs to synergistically induce many cytokines, including TNF, IL-10 and IL-23, while repressing others, such as IL- 12 (refs. 61-64) . Other examples include mannose receptor-mediated production of IL-17, which is dependent on TLR2 and Dectin-1, and DC-SIGN, which does not directly induce cytokine responses but interacts with multiple TLRs to augment pro-inflammatory responses to fungi 13, 17 . How these collaborative responses are mediated is still unclear, but this regulation may involve physical interactions upon ligand binding and modification of intracellular signaling cascades, by inclusion of components such as, for example, Raf-1 (refs. 13, 65, 66) . A better understanding of these mechanisms is likely to reveal novel targets for pharmacotherapy and to lead to the development of vaccine adjuvants. Figure 3 Integration of CLR-mediated signaling directs adaptive immunity. CLR-mediated recognition of fungi drives their uptake and killing by phagocytes, and directs the development of protective T H 1 and T H 17 responses. Induction of IL-12 drives IFN-γ production by T H 1 and iNKT cells, which is critically required for the activation of phagocytes. Production of IFN-γ by self-reactive iNKT cells occurs after CLR-mediated induction of IL-12 on antigen-presenting cells. In contrast, induction of IL-1β, IL-6 and IL-23 promotes T H 17 differentiation, which drives the production of IL-17 and IL-22. These cytokines are critically required for recruitment neutrophils and production of epithelial antimicrobial peptide (AMP), and provide protection against fungal infections, particularly at the mucosa. Production of IL-17 can also be directly induced by CLRs expressed on γδ T cells, without TCR triggering.
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The importance of PRR crosstalk in the development of protective antifungal immunity is exemplified by our recent work with Fonsesaea pedrosoi. This pathogen is one of the main causative agents of chromoblastomycosis, a severe and chronic fungal disease of the skin that is very difficult to treat 67 . Notably, F. pedrosoi was recognized by CLRs, including Mincle, but was not detected by TLRs 68 . The lack of costimulation of both PRR pathways resulted in defective inflammatory responses 68 . However, exogenous administration of purified TLR ligands restored the cooperative inflammatory responses and led to pathogen clearance in mouse models, responses that were dependent on signaling cascades mediated through both Syk and MyD88 pathways 68 . Notably, a similar approach also appears to work in humans; the topical application of TLR agonists to chromoblastomycosis lesions resulted in a rapid resolution of the infection when tested in a small group of patients (G.D.B.; unpublished results). Such defects in PRR cooperativity may also underlie chronic infections caused by other fungi, including Pneumocystis sp. In fact, treatment with heat-killed Escherichia coli has been shown to clear P. carinii infection in mice, in part through the restoration of inflammatory responses 69 .
Fungi, CLRs and the inflammasome
The inflammasome is a cytoplasmic proteolytic multimeric protein complex, involving NLRs and several adaptors, which is required for the processing and activation IL-1β and IL-18 in response to pathogens 70 . Both cytokines are essential for protective antifungal immunity, particularly for driving the development of antifungal T H 17 and T H 1 responses 71 . Several inflammasome components are implicated in mediating these responses to fungi, including the adaptor associated speck-like protein (ASC), caspase-1 and two NLRs (NLRP3 and NLRC4) [71] [72] [73] [74] [75] [76] (Fig. 4) . Both NLRs are required for controlling mucosal infections with Candida sp., but only NLRP3 is involved in preventing subsequent dissemination of this pathogen 75, 77 . Whereas CLRs and TLRs can induce pro-IL1β in response to fungi, how the NLRs actually sense these pathogens to trigger activation of caspase-1 is still unclear 75 . Activation of the NLRP3 inflammasome in response to both A. fumigatus and C. albicans requires Syk kinase, as well as the respiratory burst and potassium efflux, which is suggestive of a direct involvement of CLRs 72, 76 .
More recently, a noncanonical inflammasome has been identified, whose functioning is completely dependent on Dectin-1 (ref. 78) (Fig. 4) . In this case, recognition of fungi mediated my Dectin-1 induces both pro-IL1β and production of IL-1β through activation of caspase-8 (ref. 78) . Syk-dependent signaling from this receptor induces a CARD9-Bcl-10-MALT1, scaffold which drives NF-κB activation, as described before, but this scaffold can also associate with ASC and caspase-8 to form the noncanonical inflammasome 78 . Unlike the case with NLR inflammasomes, activation of the caspase-8 inflammasome did not require particle internalization. In DCs, various strains of A. fumigatus and C. albicans appeared to induce IL-1β primarily through this pathway, although some strains also induced the caspase-1 pathway in these cells 78 .
Enhancing vaccine efficacy
CLRs, especially those limited to particular DC subsets, have been of interest as vaccine targets. One approach has been antibody-mediated targeting of these receptors 79, 80 , and Dectin-1, Dectin-2, mannose receptor and DC-SIGN have all been examined in this way and shown to variably enhance CD4 + and CD8 + T cell responses to experimental antigens [81] [82] [83] [84] . However, any direct contribution of these receptors to the subsequent immune responses has not been examined. Another strategy has been to use carbohydrate ligands of CLRs to drive vaccine responses 85, 86 . This has been tested with several carbohydrates, including various mannose-based ligands aimed at targeting the mannose receptor and DC-SIGN (although the actual receptor specificity in these studies is always questionable) as well as β-glucans aimed at targeting Dectin-1. In all cases, such as in antibody-mediated targeting, the complexing of these antigens with carbohydrates enhanced CD4 + and CD8 + T cell responses 80, 87 . Notably, β-glucan particles have also been used to systemically target macrophages via oral administration, but in this case complexed with small interfering RNA 88 .
There has also been considerable interest in using these carbohydrates to develop antifungal vaccines, for which there is a desperate need as there are currently no clinically available vaccines 1, 89 . Several approaches have been tested including, for example, a conjugate vaccine composed of the β-glucan laminarin fused to diphtheria toxoid 90 . This vaccine induced anti-β-glucan antibodies, which were protective against a range of fungi including Candida, Aspergillus and Cryptococcus species 90, 91 . Very recently, the particulate β-glucan curdlan was shown to act as a T H 17-polarizing adjuvant when used with a novel epitope from C. albicans, which provided protection against infection with several species of Candida 92 . The acquisition of vaccine immunity using a live attenuated pathogen, Blastomyces dermatitidis, also required T H 17 immunity-a response that was induced through MyD88 but not Dectin-1, although the role of other CLRs was not examined 93 . Mannose-based antifungal vaccines have also been tested in various models with various degrees of success, although mannosylation notably was essential for driving effective T cell responses against a recombinant C. neoformans protein 85, 94 .
Conclusions
The data reviewed here highlight the central role of CLRs in antifungal immunity. These receptors are essentially required for the binding and uptake of fungi by phagocytes, the induction of antifungal effector mechanisms, the production of inflammatory mediators, and the 
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Pro-IL-1β Figure 4 CLRs mediate inflammasome activation. Fungi can activate the NLRP3 and NLRC4 inflammasomes, inducing cleavage of pro-IL-1β mediated by caspase-1 and production of bioactive IL-1β. Although CLRs, such as Dectin-1, can drive the induction of pro-IL-1β, it is unclear how the intracellularly located NLRs actually sense fungi. Activation of these receptors may directly involve CLRs, as this process has been found to require Syk kinase (as well as fungal uptake, the respiratory burst and potassium efflux). More recently, Dectin-1 has been shown to activate the noncanonical caspase-8 inflammasome, which interacts directly with the Card9-Bcl-10-MALT1 complex. Activation of caspase-8 by recruitment to this signaling complex results in the cleavage of pro-IL-1β. Assembly of these inflammasomes also involves other components, including the ASC (not presented here).
r e v i e w direction and modulation of adaptive immune responses. Although the functions of CLRs have been extensively studied in myeloid cells, it is likely that these receptors are also expressed in the epithelium. Indeed, a recent study has shown that expression of Dectin-1 can be induced in bronchial epithelial cells in vitro, and this results in the stimulation of antimicrobial and inflammatory responses in response to Aspergillus fumigatus infection 95 . Having a better understanding of the function of CLRs on nonmyeloid cells is likely to provide important insights into protective host responses, given that the majority of our normal interactions with fungi occur at the epithelium 96 .
The ability of CLRs to drive adaptive immunity, particularly T H 17 responses, has been of particular interest as these hallmark responses are essential for protection against fungal infections. The ability of CLRs to stimulate adaptive immunity also represents a strategy for vaccination, and methodologies that use the antigenicity and adjuvanticity of CLRs could provide powerful solutions for protecting against fungal and other diseases in the future. Enhancement of this adjuvanticity could potentially be achieved by taking advantage of the synergism that these receptors display when co-stimulated with other PRRs, particularly the TLRs.
Most CLRs can recognize endogenous ligands (although few of these ligands have actually been identified), and these receptors are therefore likely to also have homeostatic roles. One of the best examples is the mannose receptor, which has a well established role as a regulator of serum glycoprotein homeostasis 97 . Although CLRs are largely associated with fungi, there is also evidence that CLRs are involved in immunity to several other pathogens. DC-SIGN, mannose receptor, Dectin-1, Dectin-2 and Mincle, for example, have all been implicated in antimycobacterial immunity 98 . Considering the number of CLRs in our genomes and their conservation during evolution 99 , it would not be surprising if these receptors are found to be far more extensively involved in antimicrobial immunity in the future.
